While Americans are still waiting for one or more vaccines to be certified for Covid-19, the administration already has an idea how to distribute them so that ultimately "every American interested in it gets a copy." As we read in a report presented at the congress by the US Ministry of Health and Humanitarian Aid and the Department of Defense, the vaccine will be distributed without any upfront payments to suppliers and out-of-pocket expenses for recipients, i.e. simply ... for free for every citizen who will want get vaccinated.
However, the so-called priority populations in order to avoid the situation that in the event of market shortages the most vulnerable groups will be disadvantaged, and only later, when the market is saturated, availability will be widespread. Even more interestingly, a separate document states that a limited number of vaccines may be available as early as November this year, provided the FDA approves them, so the Americans really are not going to delay.
And it is hardly surprising, because although the United States accounts for 4% of the world's population, it has 25% of all coronavirus cases, and the number of deaths per day will reach 200,000. According to local experts, including the leading U.S. epidemiologist Dr. Anthony Fauci, the U.S. is the country most affected by the pandemic in the world, and all because they failed to implement a lockdown in a timely and effective manner - many people traveled unnecessarily, shopped in shopping centers trade and indulged in other infection-friendly activities, while the rest of the world already obeyed the restrictions.
When it comes to vaccination, the 7 most serious candidates are currently being tested in the United States, and each of them is in the final stages, one step away from FDA approval. We have around 50 promising vaccinations in the human testing phase and dozens more in the earlier stages around the world, so there is a good chance that more than one effective vaccine will be on the market soon. The only question is what numbers are hitting the market, because if we currently have a problem with even acquiring flu vaccination, the matter is serious, and it should also be taken into account that not everyone wants to get vaccinated - one in five Americans declares a refusal and a third have some doubts, which complicates the government's plans a bit.